3rd Circ. Declines To Reconsider J&J Remicade Antitrust Case
The full Third Circuit on Monday declined to reconsider a panel's September ruling sending antitrust claims from Rochester Drug Cooperative Inc. over allegedly inflated prices it paid for the Johnson &...To view the full article, register now.
Already a subscriber? Click here to view full article